BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 10584701)

  • 21. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: recognition of new variants and differential diagnosis.
    Meis-Kindblom JM; Sjögren H; Kindblom LG; Peydró-Mellquist A; Röijer E; Aman P; Stenman G
    Virchows Arch; 2001 Aug; 439(2):141-51. PubMed ID: 11561754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interphase cytogenetic analysis of myxoid soft tissue tumors by fluorescence in situ hybridization and DNA flow cytometry using paraffin-embedded tissue.
    Aoki T; Hisaoka M; Kouho H; Hashimoto H; Nakata H
    Cancer; 1997 Jan; 79(2):284-93. PubMed ID: 9010102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.
    Mariño-Enríquez A; Fletcher CD; Dal Cin P; Hornick JL
    Am J Surg Pathol; 2010 Aug; 34(8):1122-31. PubMed ID: 20588177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extensive lipoma-like changes of myxoid liposarcoma: morphologic, immunohistochemical, and molecular cytogenetic analyses.
    Iwasaki H; Ishiguro M; Nishio J; Aoki M; Yokoyama R; Yokoyama K; Taguchi K; Nabeshima K
    Virchows Arch; 2015 Apr; 466(4):453-64. PubMed ID: 25650275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myxoid liposarcoma with adipocytic maturation: detection of TLS/CHOP fusion gene transcript.
    Nakanishi H; Araki N; Joyama S; Higuchi C; Mano M; Ishiguro S; Itoh K; Ueda T; Yoshikawa H
    Diagn Mol Pathol; 2004 Jun; 13(2):92-6. PubMed ID: 15167010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas.
    Domoto H; Hosaka T; Oikawa K; Ohbayashi T; Ishida T; Izumi M; Iwaya K; Toguchida J; Kuroda M; Mukai K
    Pathol Int; 2002 Aug; 52(8):497-500. PubMed ID: 12366807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinction between lipoma and liposarcoma by MDM2 alterations: a case report of simultaneously occurring tumors and review of the literature.
    Boltze C; Schneider-Stock R; Jäger V; Roessner A
    Pathol Res Pract; 2001; 197(8):563-8. PubMed ID: 11518050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Well-differentiated/dedifferentiated liposarcoma associated with myxoid-like morphology: a clinicopathological and molecular genetic characteristics analysis of 34 cases].
    Xue S; Liu QY; Gou XN; Zhao YW; Cheng Q; Kong LF
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):168-173. PubMed ID: 38281785
    [No Abstract]   [Full Text] [Related]  

  • 29. Molecular aberrations of the G1-S checkpoint in myxoid and round cell liposarcoma.
    Dei Tos AP; Piccinin S; Doglioni C; Vukosavljevic T; Mentzel T; Boiocchi M; Fletcher CD
    Am J Pathol; 1997 Dec; 151(6):1531-9. PubMed ID: 9403703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A clinicopathologic comparison of malignant fibrous histiocytoma and liposarcoma.
    Spanier SS; Floyd J
    Instr Course Lect; 1989; 38():407-17. PubMed ID: 2539413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection.
    Butò S; Pierotti MA; Tamborini E; Della Torre G; Lavarino C; Rilke F; Pilotti S
    Diagn Mol Pathol; 1999 Sep; 8(3):125-30. PubMed ID: 10565683
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vulvar Myxoid Liposarcoma and Well Differentiated Liposarcoma With Molecular Cytogenetic Confirmation: Case Reports With Review of Malignant Lipomatous Tumors of the Vulva.
    Schoolmeester JK; Leifer AJ; Wang L; Hameed MR
    Int J Gynecol Pathol; 2015 Jul; 34(4):390-5. PubMed ID: 25851712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paratesticular dedifferentiated liposarcoma with prominent myxoid stroma: report of a case and review of the literature.
    Tajima S; Koda K
    Med Mol Morphol; 2017 Jun; 50(2):112-116. PubMed ID: 25986682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma.
    Dei Tos AP; Doglioni C; Piccinin S; Maestro R; Mentzel T; Barbareschi M; Boiocchi M; Fletcher CD
    J Pathol; 1997 Jan; 181(1):8-13. PubMed ID: 9071997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoclonality of multifocal myxoid liposarcoma: confirmation by analysis of TLS-CHOP or EWS-CHOP rearrangements.
    Antonescu CR; Elahi A; Healey JH; Brennan MF; Lui MY; Lewis J; Jhanwar SC; Woodruff JM; Ladanyi M
    Clin Cancer Res; 2000 Jul; 6(7):2788-93. PubMed ID: 10914725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [From cytogenetics to cytogenomics of adipose tissue tumors: 2. Malignant adipose tissue tumors].
    Pedeutour F; Maire G; Sirvent N;
    Bull Cancer; 2004 Apr; 91(4):317-23. PubMed ID: 15242313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.
    Shimada S; Ishizawa T; Ishizawa K; Kamada K; Hirose T
    Virchows Arch; 2005 Nov; 447(5):835-41. PubMed ID: 16012847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas.
    McCormick D; Mentzel T; Beham A; Fletcher CD
    Am J Surg Pathol; 1994 Dec; 18(12):1213-23. PubMed ID: 7977944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
    Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
    Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.